Basics Passage Bio, Inc. IPO Date: February 28, 2020 Sector: Healthcare Industry: Biotech Market Cap: $22.26M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 4.18% Avg Daily Range (30 D): $0.02 | 6.77% Avg Daily Range (90 D): $0.02 | 5.70% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): .25M Avg Daily Volume (90 D): .16M Trade Size Avg Trade Size (Sh.): 145 Avg Trade Size (Sh.) (30 D): 653 Avg Trade Size (Sh.) (90 D): 574 Institutional Trades Total Inst.Trades: 242 Avg Inst. Trade: $1.94M Avg Inst. Trade (30 D): $1.33M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.49M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 162.16K         News Mar 4, 2025 @ 3:55 PM 2025 Market Prospects of Adeno-Associated Virus Ve... Source: Researchandmarkets.Com Feb 26, 2025 @ 12:00 PM Passage Bio to Participate in Upcoming Investor Co... Source: N/A Nov 6, 2024 @ 12:00 PM Passage Bio to Present at Guggenheim Securities He... Source: N/A Aug 30, 2024 @ 11:00 AM Passage Bio to Present at H.C. Wainwright 26th Ann... Source: N/A Jul 16, 2024 @ 11:11 AM Passage Bio Announces Positive Feedback from FDA o... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.02 $-.25 $-.2 Diluted EPS $-1.02 $-.25 $-.2 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -63.46M $ -15.41M $ -12.73M Operating Income / Loss $ -68.81M $ -16.46M $ -14.27M Cost of Revenue $ $ $ Net Cash Flow $ .8M $ M $ 5.28M PE Ratio     Splits Jun 01, 2004:   20:1